Suppr超能文献

抑制肾小管上皮细胞中的 PFKP 可抑制 TGF-β 诱导的糖酵解和肾纤维化。

Inhibition of PFKP in renal tubular epithelial cell restrains TGF-β induced glycolysis and renal fibrosis.

机构信息

Department of Geriatrics, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong, China.

Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical Research Center for Geriatrics, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong, China.

出版信息

Cell Death Dis. 2023 Dec 12;14(12):816. doi: 10.1038/s41419-023-06347-1.

Abstract

Metabolic reprogramming to glycolysis is closely associated with the development of chronic kidney disease (CKD). Although it has been reported that phosphofructokinase 1 (PFK) is a rate-limiting enzyme in glycolysis, the role of the platelet isoform of PFK (PFKP) in kidney fibrosis initiation and progression is as yet poorly understood. Here, we investigated whether PFKP could mediate the progression of kidney interstitial fibrosis by regulating glycolysis in proximal tubular epithelial cells (PTECs). We induced PFKP overexpression or knockdown in renal tubules via an adeno-associated virus (AAV) vector in the kidneys of mice following unilateral ureteral occlusion. Our results show that the dilated tubules, the area of interstitial fibrosis, and renal glycolysis were promoted by proximal tubule-specific overexpression of PFKP, and repressed by knockdown of PFKP. Furthermore, knockdown of PFKP expression restrained, while PFKP overexpression promoted TGF-β1-induced glycolysis in the human PTECs line. Mechanistically, Chip-qPCR revealed that TGF-β1 recruited the small mothers against decapentaplegic (SMAD) family member 3-SP1 complex to the PFKP promoter to enhance its expression. Treatment of mice with isorhamnetin notably ameliorated PTEC-elevated glycolysis and kidney fibrosis. Hence, our results suggest that PFKP mediates the progression of kidney interstitial fibrosis by regulating glycolysis in PTECs.

摘要

糖酵解代谢重编程与慢性肾脏病(CKD)的发展密切相关。尽管已有报道称磷酸果糖激酶 1(PFK)是糖酵解的限速酶,但血小板同工酶 PFK(PFKP)在肾脏纤维化起始和进展中的作用尚不清楚。在这里,我们研究了 PFKP 是否可以通过调节近端肾小管上皮细胞(PTEC)中的糖酵解来介导肾脏间质纤维化的进展。我们通过腺相关病毒(AAV)载体在单侧输尿管梗阻后肾脏中的肾小管中诱导 PFKP 的过表达或敲低,从而在小鼠中实现了这一点。我们的结果表明,近端肾小管特异性过表达 PFKP 促进了扩张的肾小管、间质纤维化面积和肾脏糖酵解,而敲低 PFKP 则抑制了这些过程。此外,敲低 PFKP 表达可抑制,而 PFKP 过表达则促进 TGF-β1 诱导的人 PTEC 系中的糖酵解。从机制上讲,Chip-qPCR 显示 TGF-β1 募集小母亲抗 decapentaplegic(SMAD)家族成员 3-SP1 复合物到 PFKP 启动子以增强其表达。异鼠李素治疗显著改善了 PTEC 升高的糖酵解和肾脏纤维化。因此,我们的结果表明 PFKP 通过调节 PTEC 中的糖酵解来介导肾脏间质纤维化的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e186/10716164/3103f2ca4c2e/41419_2023_6347_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验